BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorecki AM, Bakeberg MC, Theunissen F, Kenna JE, Hoes ME, Pfaff AL, Akkari PA, Dunlop SA, Kõks S, Mastaglia FL, Anderton RS. Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease. Front Aging Neurosci 2020;12:603849. [PMID: 33328979 DOI: 10.3389/fnagi.2020.603849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Xiromerisiou G, Marogianni C, Androutsopoulou A, Ntavaroukas P, Mysiris D, Papoutsopoulou S. Parkinson's Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration. Biology (Basel) 2023;12. [PMID: 36671785 DOI: 10.3390/biology12010093] [Reference Citation Analysis]
2 Su J, Deng Y, Cai B, Teng S, Zhang S, Liu Y, Lin J, Yang Q, Zeng D, Zhao X, Chen T. PI3K polymorphism in patients with sporadic Parkinson's disease. Medicine (Baltimore) 2022;101:e32349. [PMID: 36595764 DOI: 10.1097/MD.0000000000032349] [Reference Citation Analysis]
3 Liang F, Chen CY, Li YP, Ke YC, Ho EP, Jeng CF, Lin CH, Chen SK. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease. J Parkinsons Dis 2022;12:2423-40. [PMID: 36155528 DOI: 10.3233/JPD-223431] [Reference Citation Analysis]
4 Schrag A, Bohlken J, Dammertz L, Teipel S, Hermann W, Akmatov MK, Bätzing J, Holstiege J. Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease. JAMA Neurol 2022. [DOI: 10.1001/jamaneurol.2022.3902] [Reference Citation Analysis]
5 Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. J Biomed Sci 2022;29:54. [PMID: 35897024 DOI: 10.1186/s12929-022-00839-6] [Reference Citation Analysis]
6 Warnecke T, Schäfer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis 2022;8:31. [PMID: 35332158 DOI: 10.1038/s41531-022-00295-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Luan M, Jin J, Wang Y, Li X, Xiea A. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neurosci Lett 2022;:136547. [PMID: 35218888 DOI: 10.1016/j.neulet.2022.136547] [Reference Citation Analysis]
8 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
9 Su WM, Gu XJ, Hou YB, Zhang LY, Cao B, Ou RW, Wu Y, Chen XP, Song W, Zhao B, Shang HF, Chen YP. Association Analysis of WNT3, HLA-DRB5 and IL1R2 Polymorphisms in Chinese Patients With Parkinson's Disease and Multiple System Atrophy. Front Genet 2021;12:765833. [PMID: 34868249 DOI: 10.3389/fgene.2021.765833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gorecki AM, Anyaegbu CC, Anderton RS. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 2021;10:47. [PMID: 34814947 DOI: 10.1186/s40035-021-00271-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bakeberg MC, Hoes ME, Gorecki AM, Theunissen F, Pfaff AL, Kenna JE, Plunkett K, Kõks S, Akkari PA, Mastaglia FL, Anderton RS. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease. Sci Rep 2021;11:6363. [PMID: 33737565 DOI: 10.1038/s41598-021-85510-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]